PSNC Briefing 032/22: Pharmacy Quality Scheme – Asthma referrals

This PSNC Briefing provides contractors with guidance for the 2022/23 Pharmacy Quality Scheme (PQS) on meeting the following criteria, which are part of the Respiratory domain:

• Use of a spacer in patients aged 5-15 years;
• Personalised asthma action plans (PAAPs); and
• Referrals for patients using three or more short-acting bronchodilator inhalers without a corticosteroid inhaler in six months.

PSNC Briefing 032/22: Pharmacy Quality Scheme – Asthma referrals

The Briefing also contains four annexes which are available below as separate documents:

Annex A. suggested process for referrals for patients aged 5 years and above who do not have a Personalised Asthma Action Plan (PAAP) and/or children aged 5-15 years who have been prescribed a press and breathe pressurised MDI for asthma without a spacer

Annex B. suggested process for referring patients for an asthma review for patients who have had three or more short-acting bronchodilator inhalers dispensed without a corticosteroid within a six month period

Annex C. Referral form (Word)

Annex C. Referral form  (PDF)

Annex D. Data collection form (Word)

Annex D. Data collection form (PDF)

For more information on this topic please email services.team@cpe.org.uk